4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0002034665-25-000006
President and COO sold 12,500 shares at $18.16 ($226,943)
- President and COO acquired 8,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohlhepp Ryan President and COO | 2025-10-15 | Option exercise 10b5-1 | +8,000 | $3.79 | $30,318 | 210,641 | D |
| Cohlhepp Ryan President and COO | 2025-10-15 | Sale 10b5-1 | −8,000 | $18.16 | $145,243 | 202,641 | D |
| Cohlhepp Ryan President and COO | 2025-10-15 | Sale 10b5-1 | −4,500 | $18.16 | $81,699 | 198,141 | D |
| Derivatives | |||||||
| Cohlhepp Ryan President and COO | 2025-10-15 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,000 | 157,334 | D | ||
| Open-market sales · 12,500 sh · avg $18.16 · $226,943 | |||||||
Loading xslF345X05/wk-form4_1760647298.xml…